Diabetes, Obesity and Metabolism, 1462-8902

Tidskrift

Fler filtreringsmöjligheter
  1. 1999
  2. Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project

    Östgren, C. J., Lindblad, U., Bøg-Hansen, E., Jonas Ranstam, Melander, A. & Lennart Råstam, 1999, I : Diabetes, Obesity and Metabolism. 1, 2, s. 105-112

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2001
  4. Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes

    Jönsson, A., Bengt Hallengren, Rydberg, T. & Melander, A., 2001, I : Diabetes, Obesity and Metabolism. 3, 6, s. 403-409

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project

    Bøg-Hansen, E., Lindblad, U., Ranstam, J., Melander, A. & Lennart Råstam, 2001, I : Diabetes, Obesity and Metabolism. 3, 1, s. 25-31

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2002
  7. Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes.

    Hermann, LS., Lindberg, G., Lindblad, U. & Melander, A., 2002, I : Diabetes, Obesity and Metabolism. 4, 5, s. 296-304

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  8. 2003
  9. Metabolic disorders associated with uncontrolled hypertension.

    Bøg-Hansen, E., Lindblad, U., Bo Gullberg, Melander, A. & Lennart Råstam, 2003, I : Diabetes, Obesity and Metabolism. 5, 6, s. 379-387

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study.

    Lidfeldt, J., Nyberg, P., Nerbrand, C., Samsioe, G., Scherstén, B. & Agardh, C-D., 2003, I : Diabetes, Obesity and Metabolism. 5, 2, s. 106-112

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2004
  12. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.

    Östgren, C. J., Juan Merlo, Lennart Råstam & Lindblad, U., 2004, I : Diabetes, Obesity and Metabolism. 6, 5, s. 367-374

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2005
  14. Islet adaptation to insulin resistance: mechanisms and implications for intervention.

    Bo Ahrén & Pacini, G., 2005, I : Diabetes, Obesity and Metabolism. 7, 1, s. 2-8

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  15. 2006
  16. Residual risk for acute stroke in patients with type 2 diabetes and hypertension in primary care: Skaraborg Hypertension and Diabetes Project.

    Jungå, K., Juan Merlo, Bo Gullberg, Bog-Hansen, E., Lennart Råstam & Lindblad, U., 2006, I : Diabetes, Obesity and Metabolism. 8, 5, s. 492-500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. 2007
  18. Prediction of fat-free body mass from bioelectrical impedance among 9-to 11-year-old Swedish children

    Nielsen, B. M., Magnus Dencker, Ward, L., Christian Lindén, Ola Thorsson, Magnus Karlsson & Heitmann, B. L., 2007, I : Diabetes, Obesity and Metabolism. 9, 4, s. 521-539

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial

    Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Frandsen, M., Smidt, U. M., Pedersen, O., Parving, H. -H. & Allan Vaag, 2007, I : Diabetes, Obesity and Metabolism. 9, 3, s. 394-407

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2008
  21. Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up

    Alvarsson, M., Sundkvist, G., Lager, I., Kerstin Berntorp, Fernqvist-Forbes, E., Steen, L., Örn, T., Holberg, M. A., Kirksaether, N. & Grill, V., 2008, I : Diabetes, Obesity and Metabolism. 10, 5, s. 421-429

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia

    Scherbaum, W. A., Schweizer, A., Mari, A., Peter Nilsson, Lalanne, G., Jauffret, S. & Foley, J. E., 2008, I : Diabetes, Obesity and Metabolism. 10, 8, s. 675-682

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia

    Scherbaum, W. A., Schweizer, A., Mari, A., Peter Nilsson, Lalanne, G., Wang, Y., Dunning, B. E. & Foley, J. E., 2008, I : Diabetes, Obesity and Metabolism. 10, 11, s. 1114-1124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Retinopathy in subjects with impaired fasting glucose The NANSY – Eye Study, Baseline report

    Tyrberg, M., Melander, A., Monica Lövestam Adrian & Lindblad, U., 2008, I : Diabetes, Obesity and Metabolism. 10, 8, s. 646-651

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2009
  26. beta-Cell research - A decade of rapid growth

    Bo Ahrén, Accili, D., Boitard, C., Efendic, S., Henquin, J-C., Seino, S., Steiner, D. F. & Cerasi, E., 2009, I : Diabetes, Obesity and Metabolism. 11, s. IV-IX

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery

    Guldstrand, M., Bo Ahrén, Naslund, E., Holst, J. J. & Adamson, U., 2009, I : Diabetes, Obesity and Metabolism. 11, 11, s. 1027-1033

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes

    Lund, S. S., Tarnow, L., Astrup, A. S., Hovind, P., Jacobsen, P. K., Alibegovic, A. C., Parving, I., Pietraszek, L., Frandsen, M., Rossing, P., Parving, H. -H. & Allan Vaag, 2009, I : Diabetes, Obesity and Metabolism. 11, 10, s. 966-977

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

    Ferrannini, E., Fonseca, V., Zinman, B., Matthews, D., Bo Ahrén, Byiers, S., Shao, Q. & Dejager, S., 2009, I : Diabetes, Obesity and Metabolism. 11, 2, s. 157-166

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Functional SOCS1 polymorphisms are associated with variation in obesity in whites

    Gylvin, T., Ek, J., Nolsoe, R., Albrechtsen, A., Andersen, G., Bergholdt, R., Brorsson, C., Bang-Berthelsen, C. H., Hansen, T., Karlsen, A. E., Billestrup, N., Borch-Johnsen, K., Jorgensen, T., Pedersen, O., Mandrup-Poulsen, T., Nerup, J. & Pociot, F., 2009, I : Diabetes, Obesity and Metabolism. 11, 3, s. 196-203

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Genetic basis of beta-cell dysfunction in man.

    Leif Groop & Valeriya Lyssenko, 2009, I : Diabetes, Obesity and Metabolism. 11 Suppl 4, s. 149-158

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data

    Brorsson, C., Hansen, N. T., Lage, K., Bergholdt, R., Brunak, S. & Pociot, F., 2009, I : Diabetes, Obesity and Metabolism. 11, S1, s. 60-66

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.

    Vikman, J. & Bo Ahrén, 2009, I : Diabetes, Obesity and Metabolism. 11 Suppl 4, s. 197-201

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. 2010
  35. A low glycaemic diet improves oral glucose tolerance but has no effect on β-cell function in C57BL/6J mice.

    Ulrika Axling, Rosén, L., Nils Wierup, Östman, E., Björck, I. & Cecilia Holm, 2010, I : Diabetes, Obesity and Metabolism. 12, 11, s. 976-982

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

    Matthews, D. R., Dejager, S., Bo Ahrén, Fonseca, V., Ferrannini, E., Couturier, A., Foley, J. E. & Zinman, B., 2010, I : Diabetes, Obesity and Metabolism. 12, 9, s. 780-789

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. What ails the beta-cell?

    Accili, D., Bo Ahrén, Boitard, C., Cerasi, E., Henquin, J. -C. & Seino, S., 2010, I : Diabetes, Obesity and Metabolism. 12, s. 1-3

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  38. 2011
  39. Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)

    Lindblad, U., Lindberg, G., Månsson, N-O., Jonas Ranstam, Tyrberg, M., Jansson, S., Lindwall, K., Svärdh, M., Kindmalm, L. & Melander, A., 2011, I : Diabetes, Obesity and Metabolism. 13, 2, s. 185-188

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.

    Bo Ahrén, Foley, J. E. & Bosi, E., 2011, I : Diabetes, Obesity and Metabolism. 13, 3, s. 193-203

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.

    Ola Lindgren, Carr, R., Holst, J. J., Deacon, C. & Bo Ahrén, 2011, I : Diabetes, Obesity and Metabolism. 13, s. 863-865

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Editorial: Long in the shade, glucagon re-occupies centre court

    Henquin, J. -C., Accili, D., Bo Ahrén, Boitard, C., Seino, S. & Cerasi, E., 2011, I : Diabetes, Obesity and Metabolism. 13, Suppl. 1, s. V-VIII

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  43. Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.

    Alam, M., Van der Schueren, B. J., Bo Ahrén, Wang, G. C., Swerdlow, N. J., Arias, S., Bose, M., Gorroochurn, P., Teixeira, J., McGinty, J. & Laferrère, B., 2011, I : Diabetes, Obesity and Metabolism. 13, 4, s. 378-381

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.

    Bo Ahrén, Schweizer, A., Dejager, S., Villhauer, E. B., Dunning, B. E. & Foley, J. E., 2011, I : Diabetes, Obesity and Metabolism. 13, 9, s. 775-783

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  45. The future of incretin-based therapy: novel avenues-novel targets.

    Bo Ahrén, 2011, I : Diabetes, Obesity and Metabolism. 13 Suppl 1, s. 158-166

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 2012
  47. The hyperstimulated beta-cell: prelude to diabetes?

    Boitard, C., Accili, D., Bo Ahrén, Cerasi, E., Seino, S. & Thorens, B., 2012, I : Diabetes, Obesity and Metabolism. 14, S3, s. iv-viii

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  48. Using albumin to improve the therapeutic properties of diabetes treatments.

    Bo Ahrén & Burke, B., 2012, I : Diabetes, Obesity and Metabolism. 14, s. 121-129

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. 2013
  50. Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials

    Monami, M., Bo Ahrén, Dicembrini, I. & Mannucci, E., 2013, I : Diabetes, Obesity and Metabolism. 15, 2, s. 112-120

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.

    Lena Ohlsson, Alsalim, W., Carr, R. D., Tura, A., Pacini, G., Mari, A. & Bo Ahrén, 2013, I : Diabetes, Obesity and Metabolism. 15, 6, s. 531-537

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

    Nauck, M., Frid, A., Hermansen, K., Thomsen, A. B., During, M., Shah, N., Tankova, T., Mitha, I. & Matthews, D. R., 2013, I : Diabetes, Obesity and Metabolism. 15, 3, s. 204-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Shifting the paradigm of islet inflammation-good guy or bad guy?

    Bo Ahrén, Accili, D., Boitard, C., Cerasi, E., Thorens, B. & Seino, S., 2013, I : Diabetes, Obesity and Metabolism. 15, s. 4-9

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  54. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

    Alba, M., Bo Ahrén, Inzucchi, S. E., Guan, Y., Mallick, M., Xu, L., O'Neill, E. A., Williams-Herman, D. E., Kaufman, K. D. & Goldstein, B. J., 2013, I : Diabetes, Obesity and Metabolism. 15, 12, s. 1101-1110

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. 2014
  56. Pronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.

    Bo Ahrén, Gautier, J-F., Berria, R., Stager, W., Aronson, R. & Bailey, C. J., 2014, I : Diabetes, Obesity and Metabolism. 16, 9, s. 861-868

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. The mind and the belly: a glance at how the nervous system directs metabolism

    Accili, D., Bo Ahrén, Boitard, C., Seino, S., Thorens, B. & Cerasi, E., 2014, I : Diabetes, Obesity and Metabolism. 16, s. 1-3

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  58. 2015
  59. The Islet and Metabolism Keep Time

    Thorens, B., Accili, D., Bo Ahrén, Cerasi, E., Seino, S. & Boitard, C., 2015, I : Diabetes, Obesity and Metabolism. 17, Suppl 1, s. 3-5

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  60. 2016
  61. Mixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.

    Alsalim, W., Tura, A., Pacini, G., Omar, B., Bizzotto, R., Mari, A. & Bo Ahrén, 2016, I : Diabetes, Obesity and Metabolism. 18, 1, s. 24-33

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  62. 2017
  63. Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial

    Yabe, D., Eto, T., Shiramoto, M., Irie, S., Murotani, K., Seino, Y., Kuwata, H., Kurose, T., Seino, S., Bo Ahrén & Seino, Y., 2017, I : Diabetes, Obesity and Metabolism. 19, 3, s. 442-447

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa